<DOC>
	<DOCNO>NCT02210247</DOCNO>
	<brief_summary>The purpose study evaluate safety pharmacokinetics redo EXPAREL via local subcutaneous infiltration healthy volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetics Study Redosing EXPAREL Healthy Volunteers</brief_title>
	<detailed_description>During Dosing Period 1 , blood sample pharmacokinetic ( PK ) analysis obtain predose ( 15 minute prior administration EXPAREL ) 12 hour postdose ( i.e. , 15 30 minute , 1 , 2 , 4 , 8 , 12 hour ) Cohort 4 ; 36 hour postdose ( i.e. , 15 30 minute , 1 , 2 , 4 , 8 , 12 , 24 , 36 hour ) Cohort 3 ; 60 hour postdose ( i.e. , 15 30 minute , 1 , 2 , 4 , 8 , 12 , 24 , 36 , 48 , 60 hour ) Cohort 2 ; 72 hour postdose ( i.e. , 15 30 minute , 1 , 2 , 4 , 8 , 12 , 24 , 36 , 48 , 60 , 72 hour ) Cohorts 1 5 . During Dosing Period 2 ( Cohorts 2 , 3 , 4 ) , blood sample PK analysis obtain predose ( 15 minute prior administration EXPAREL ) 72 hour postdose ( i.e. , 15 30 minute , 1 , 2 , 4 , 8 , 12 , 24 , 36 , 48 , 60 , 72 hour ) .</detailed_description>
	<criteria>Males female â‰¥18 year age . American Society Anesthesiologists ( ASA ) physical status 1 2 . Female subject must surgically sterile , least 2 year postmenopausal , use medically acceptable method birth control . If childbearing potential , must document negative pregnancy test within 24 hour first study drug administration . Able provide inform consent , adhere study visit schedule , complete study assessment . History hypersensitivity idiosyncratic reaction amidetype local anesthetic . History abnormal bleeding tendencies/clotting disorder . Regular use anticoagulant ( except low dose aspirin cardioprotection ) . Received investigational drug within 30 day prior study drug administration , and/or plan administration another investigational product procedure his/her participation study . Currently pregnant , nursing , plan become pregnant study within 1 month study drug administration . Subjects significant medical condition laboratory result , opinion Investigator , would constitute contraindication participation study , cause inability comply study requirement . Received bupivacaine local anesthetic within 7 day first study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>